CARCINOMAS
Clinical trials for CARCINOMAS explained in plain language.
Never miss a new study
Get alerted when new CARCINOMAS trials appear
Sign up with your email to follow new studies for CARCINOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to prevent lung cancer recurrence in High-Risk patients
⭐️ VACCINE ⭐️ TerminatedThis study tests a vaccine made from lung cancer cells, combined with an immune-boosting drug (N-803), to see if it can prevent non-small cell lung cancer from returning after surgery. About 30 adults with no signs of cancer after surgery will receive the vaccine as shots under t…
Matched conditions: CARCINOMAS
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 12:45 UTC
-
New hope for rare cervical cancer: drug trial targets tumor control
Disease control OngoingThis study tests a drug called AK104 (cadonilimab) in 18 adults with a rare and fast-growing type of cervical cancer that has come back or spread. The goal is to see if the drug can stop the cancer from growing for at least 6 months. Participants must have already tried standard …
Matched conditions: CARCINOMAS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 12:53 UTC
-
New hope for rare kidney cancer: immunotherapy combo under study
Disease control OngoingThis study tests whether combining two immunotherapy drugs, nivolumab and relatlimab, can shrink or control a rare and aggressive kidney cancer called renal medullary carcinoma (RMC). The trial includes 30 adults whose cancer has spread or cannot be removed by surgery. The goal i…
Matched conditions: CARCINOMAS
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:46 UTC